Abstract
Continuing Medical Education Information.
Highlights
Time to Complete Activity: 4.0 Hours. This activity has been designed to address the educational needs of neuro-oncologists
It may be of benefit to other clinicians interested or involved in the treatment of patients with neurofibromatosis
There is no fee required for participation in this activity
Summary
To receive a CME certificate of participation, you should:. Read the entire publication, including the CME information Register or log in at www.paradigmmc.com/a942 to complete and submit the online posttest and evaluation. To receive a CME certificate of participation, you should:. Read the entire publication, including the CME information Register or log in at www.paradigmmc.com/a942 to complete and submit the online posttest and evaluation. Following online completion of the posttest and evaluation, a certificate of participation will be available for download/ printing immediately. There is no fee required for participation in this activity. This activity is provided by Paradigm Medical Communications, LLC. Upon proper completion of this activity, participants should be better able to:. Interpret efficacy and safety data from the latest clinical trials investigating MEK inhibitors for treatment of neurofibromas. Describe the importance of developing new measures of quality of life to facilitate the design of clinical trials in NF1
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
